Pediatric chronic lower respiratory disorders: Microbiological and immunological phenotype123. Issue 8 (19th September 2012)

• Record Type: Journal Article
• Authors: Bugin, S.; Lunardi, F.; Bertuola, F.; Snijders, D.; Bottecchia, L.; Perissinotto, E.; Calabrese, F.; Barbato, A.
• Is Part Of: Pediatric pulmonology. Volume 48:Issue 8(2013:Aug.)
• Page Start: 780
• Page End: 788
• Publication Date: 2012-09-19
• Subjects: Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.22677
• Languages: English
• ISSNs: 8755-6863

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>The role of infectious agents in children with recurrent/chronic lower respiratory disorders (R/CLRDs) is not clear, whereas it has been largely studied in acute respiratory diseases. The purpose of the study was to evaluate the frequency of infections, in particular viral infections, in children with R/CLRDs correlating their presence with clinical/biohumoral parameters.</p> <p>Eighty children affected by R/CLRDs underwent bronchoscopy and analysis of bronchoalveolar lavage (BAL) for cells, mediators (eosinophil cationic protein—ECP, interleukin—IL‐8, tumor necrosis factor—TNFα) and pathogens (viruses and bacteria).</p> <p>Viral genomes were detected in 50/80 (62.5%) children. Rhinovirus, the principal detected virus (26/50, 52%), occurred more frequently in male children. Higher percentages of BAL neutrophils and IL‐8 values were detected in virus positive than negative children.</p> <p>ECP values resulted significantly higher in the children with rhinovirus than in those with other viruses. No other statistically significant correlation between viral findings and clinical/biohumoral data were found.</p> <p>Respiratory viruses, especially rhinovirus, seem to play an important role in children with R/CLRDs. They are associated with changes in BAL cellularity and inflammatory cytokines. Further studies are needed to confirm the persistence of viruses in these patients and to identify eventual therapeutic strategies. Pediatr Pulmonol. 2013; 48:780–788. © 2012 Wiley Periodicals, Inc.</p> </abstract>